n South African Journal of Child Health - Treatment and outcome of hospitalised, very young, HIV-infected children

Volume 1, Issue 4
  • ISSN : 1994-3032
  • E-ISSN: 1999-7671



. The aim of this study was to describe the disease severity and clinical course and outcome of hospitalised HIV-infected children aged <6 months.

. A retrospective case review was completed at Red Cross Children's Hospital (RCCH) during the middle of 2006. Perinatal management, disease severity and hospital outcomes were analysed. In a sub-analysis, the disease profile and outcome of admitted children aged less than and more than 6 months were compared over the latter 3 months of the study.
. Seventy-five out of 121 (43.86%) of all HIV infected children admitted over the study period were <6 months of age. Sixty-nine out of 72 (95.83%) of the children not receiving highly active antiretroviral therapy (HAART) at admission, qualified according to current WHO treatment criteria. The most frequent cause for admission was pneumonia (54.67%). The inpatient fatality rate was 28%, pneumonia being the most frequent cause of death (61.9%). Fifty-two out of 75 (69.33%) of the mothers reported having been tested for HIV during pregnancy. Thirty-four out of 37 (91.89%) who tested HIV-positive during pregnancy received prevention of mother-to child transmission (PMTCT) prophylaxis. Children with confirmed / presumed pneumonia (PJP) were less likely to have mothers who received PMTCT prophylaxis (18.51% . 61.7%, =0.0004), and less likely to be receiving cotrimoxazole prophylaxis (14.81% . 46.81%, =0.006) at admission. Children >6 months were more likely to be receiving cotrimoxazole prophylaxis (65.4% . 31.1%, =0.0008) and HAART (42.3% . 6.7%, =0.00007) at the time of admission. Of those not on HAART, 27 out of 30 (90%) had WHO stage 3 or 4 disease. Inpatient fatality in this group was 13.5%.
. Young children constitute a sizeable proportion of the inpatient paediatric HIV workload. Comprehensive PMTCT interventions and earlier introduction of HAART may reduce morbidity, hospitalisation rates and mortality.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error